Immunoregulatory function of mesenchymal stem cells

被引:443
作者
Uccelli, Antonio
Moretta, Lorenzo
Pistoia, Vito
机构
[1] Univ Genoa, Dept Neurosci Ophthalmol & Genet, I-16132 Genoa, Italy
[2] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy
[3] IRCSS, G Gaslini Inst, Genoa, Italy
[4] Univ Genoa, Dept Expt Med, Genoa, Italy
关键词
B cells; dendritic cells; mesenchymal stem cells; NK cells; T cells;
D O I
10.1002/eji.200636416
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mesenchymal stem cells (MSC) are a rare subset of stem cells residing in the bone marrow where they closely interact with hematopoietic stem cells and support their growth and differentiation. MSC can differentiate into multiple mesenchymal and nonmesenchymal lineages, providing a promising tool for tissue repair. In addition, MSC suppress many T cell, B cell and NK cell functions and may affect also dendritic cell activities. Due to their limited immunogenicity, MSC are poorly recognized by HLA-incompatible hosts. Based on these unique properties, MSC are currently under investigation for their possible use to treat immuno-mediated diseases. However, both their condition of immunoprivilege and their immunosuppressive function have recently been challenged when analyzed under particular experimental conditions. Thus, it is likely that MSC effects on the immune system may be deeply influenced not only by cell-to-cell interactions, but also by environmental factors shaping their phenotype and functions.
引用
收藏
页码:2566 / 2573
页数:8
相关论文
共 76 条
[1]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]   Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation [J].
Almeida-Porada, G ;
Porada, CD ;
Tran, N ;
Zanjani, ED .
BLOOD, 2000, 95 (11) :3620-3627
[3]   Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway [J].
Augello, A ;
Tasso, R ;
Negrini, SM ;
Amateis, A ;
Indiveri, F ;
Cancedda, R ;
Pennesi, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) :1482-1490
[4]   Autologous mesenchymal stem cell transplantation in stroke patients [J].
Bang, OY ;
Lee, JS ;
Lee, PH ;
Lee, G .
ANNALS OF NEUROLOGY, 2005, 57 (06) :874-882
[5]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[6]   Microenvironmental influences on human B-cell development [J].
Bertrand, FE ;
Eckfeldt, CE ;
Fink, JR ;
Lysholm, AS ;
Pribyl, JAR ;
Shah, N ;
LeBien, TW .
IMMUNOLOGICAL REVIEWS, 2000, 175 :175-186
[7]   Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness [J].
Beyth, S ;
Borovsky, Z ;
Mevorach, D ;
Liebergall, M ;
Gazit, Z ;
Aslan, H ;
Galun, E ;
Rachmilewitz, J .
BLOOD, 2005, 105 (05) :2214-2219
[8]  
CAPLAN AI, 2006, J CELL BIOCH 0417
[9]   Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-γ [J].
Chan, Jennifer L. ;
Tang, Katherine C. ;
Patel, Anoop P. ;
Bonilla, Larissa M. ;
Pierobon, Nicola ;
Ponzio, Nicholas M. ;
Rameshwar, Pranela .
BLOOD, 2006, 107 (12) :4817-4824
[10]   Human mesenchymal stem cells modulate B-cell functions [J].
Corcione, A ;
Benvenuto, F ;
Ferretti, E ;
Giunti, D ;
Cappiello, V ;
Cazzanti, F ;
Risso, M ;
Gualandi, F ;
Mancardi, GL ;
Pistoia, V ;
Uccelli, A .
BLOOD, 2006, 107 (01) :367-372